Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control

AAPS Journal

Volumn 17, Issue 3, 2015, Pages 643-651

  Zeng, Kui ^a   Geerlof Vidavisky, Ilan ^a   Gucinski, Ashley ^a   Jiang, Xiaohui ^a   Boyne, Michael T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

High resolution mass spectrometry; impurity profiling; LC HRMS; peptide drug

Indexed keywords

CALCITONIN; EXENDIN 4; HIRUDIN DERIVATIVE; HIRULOG; PEPTIDE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; SALCATONIN; VENOM;

AMINO ACID SEQUENCE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCEDURES; QUALITY CONTROL; STANDARDS;

AMINO ACID SEQUENCE; CALCITONIN; CHROMATOGRAPHY, LIQUID; HIRUDINS; LIMIT OF DETECTION; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PEPTIDES; QUALITY CONTROL; RECOMBINANT PROTEINS; VENOMS;

EID: 84939984928     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-015-9730-z     Document Type: Article

References (20)

1. Ermerand J, Vogel M. Applications of hyphenated LC-MS techniques in pharmaceutical analysis. Biomed Chromatogr. 2000;14:373–83.
2. Kasparand AA, Reichert JM. Future directions for peptide therapeutics development. Drug Discov Today. 2013;18:807–17.
3. Dorpe VS, Verbeken M, Wynendaele E, De Spiegeleer B. Purity profiling of peptide drugs. J Bioanal Biomed. 2011;15:1–15.
4. Gucinskiand AC, Boyne 2nd MT. Identification of site-specific heterogeneity in peptide drugs using intact mass spectrometry with electron transfer dissociation. Rapid Commun Mass Spectrom: RCMS. 2014;28:1757–63.
5. Ramanathan R, Jemal M, Ramagiri S, Xia YQ, Humpreys WG, Olah T, et al. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J Mass Spectrom: JMS. 2011;46:595–601.
6. Ramanathan R, Korfmacher W. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena. Bioanalysis. 2012;4:467–9.
7. Morin LP, Mess JN, Garofolo F. Large-molecule quantification: sensitivity and selectivity head-to-head comparison of triple quadrupole with Q-TOF. Bioanalysis. 2013;5:1181–93.
8. Wei H, Tymiak AA, Chen G. High-resolution MS for structural characterization of protein therapeutics: advances and future directions. Bioanalysis. 2013;5:1299–313.
9. Fung EN, Jemal M, Aubry AF. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here? Bioanalysis. 2013;5:1277–84.
10. Dillenand L, Cuyckens F. High-resolution MS: first choice for peptide quantification? Bioanalysis. 2013;5:1145–8.
11. Ermerand J, Kibat P-G. A quality concept for impurities during drug development—use of the hyphenated LC–MS technique. Pharm Sci Technol Today. 1998;1:76–82.
12. Ermer J. The use of hyphenated LC–MS technique for characterisation of impurity profiles during drug development. J Pharm Biomed Anal. 1998;18:707–14.
13. Chopra S, Pendela M, Hoogmartens J, Van Schepdael A, Adams E. Impurity profiling of capreomycin using dual liquid chromatography coupled to mass spectrometry. Talanta. 2012;100:113–22.
14. Chopra S, Van Schepdael A, Hoogmartens J, Adams E. Characterization of impurities in tylosin using dual liquid chromatography combined with ion trap mass spectrometry. Talanta. 2013;106:29–38.
15. Gucinskiand AC, Boyne 2nd MT. Evaluation of intact mass spectrometry for the quantitative analysis of protein therapeutics. Anal Chem. 2012;84:8045–51.
16. Chesnut 3rd CH, Azria M, Silverman S, Engelhardt M, Olson M, Mindeholm L. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int. 2008;19:479–91.
17. USP 36-NF 31 (United States Pharmacopeia Convention). Calcitonin salmon, calcitonin salmon injection, and calcitonin nasal solution. USP;2013. p. 2736-2741.
18. Reedand MD, Bell D. Clinical pharmacology of bivalirudin. Pharmacotherapy. 2002;22:105S–11S.
19. Cvetkovicand RS, Plosker GL. Exenatide: a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea). Drugs. 2007;67:935–54.
20. Liu B, Dong Q, Shi L, Wang M, Li C, Wu Y, et al. Development and validation of a reverse-phase high performance liquid chromatography method for determination of exenatide in poly(lactic-co-glycolic acid) microspheres. Chem Res Chin Univ. 2010;26:33–7.